BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36747204)

  • 1. SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer.
    Xu QP; Deng K; Zhang Z; Shang H
    J Ovarian Res; 2023 Feb; 16(1):33. PubMed ID: 36747204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway.
    Guo L; Liu Z; Tang X
    Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription.
    Wan G; Zhu J; Gu X; Yang Y; Liu Y; Wang Z; Zhao Y; Wu H; Huang G; Lu C
    Br J Cancer; 2020 Aug; 123(4):633-643. PubMed ID: 32488136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
    Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
    Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Long Noncoding RNA MEG3 Retains Epithelial-Mesenchymal Transition by Sponging miR-146b-5p to Regulate SLFN5 Expression in Breast Cancer Cells.
    Gu X; Li J; Zuo X; Chen K; Wan G; Deng LL; Zhao W; Lu C
    J Immunol Res; 2022; 2022():1824166. PubMed ID: 36033389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-27a promotes EMT in ovarian cancer through active Wnt/đťś·-catenin signalling by targeting FOXO1.
    Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
    Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
    Li J; Diao H; Guan X; Tian X
    Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 9. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.
    Zhu LY; Zhang WM; Yang XM; Cui L; Li J; Zhang YL; Wang YH; Ao JP; Ma MZ; Lu H; Ren Y; Xu SH; Yang GD; Song WW; Wang JH; Zhang XD; Zhang R; Zhang ZG
    Cancer Lett; 2015 Jul; 363(1):71-82. PubMed ID: 25864591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
    Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
    [No Abstract]   [Full Text] [Related]  

  • 14. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
    Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
    Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
    Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
    Huang M; Wang Q; Zhang W; Li DR; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.